The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016-Reference-Cited by-同舟云学术

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016

Published:2016-07 Issue:7 Volume:11 Page:946-963
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Tan Daniel S.W.,Yom Sue S.,Tsao Ming S.,Pass Harvey I.,Kelly Karen,Peled Nir,Yung Rex C.,Wistuba Ignacio I.,Yatabe Yasushi,Unger Michael,Mack Philip C.,Wynes Murry W.,Mitsudomi Tetsuya,Weder Walter,Yankelevitz David,Herbst Roy S.,Gandara David R.,Carbone David P.,Bunn Paul A.,Mok Tony S.K.,Hirsch Fred R.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference128 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers;Shigematsu;J Natl Cancer Inst,2005

4. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey;Yatabe;J Thorac Oncol,2015

5. Cancer genomics: diversity and disparity across ethnicity and geography;Tan;J Clin Oncol,2016

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimerinib haematological toxicities in non-small cell lung cancer: a randomised controlled trials meta-analysis;BMJ Supportive & Palliative Care;2024-08-19

2. Synthesis and evaluation of a rociletinib analog as prospective imaging double mutation L858R/T790M in non-small cell lung cancer;Journal of Pharmacy & Pharmacognosy Research;2024-03-01

3. Research progress of LSD1-based dual-target agents for cancer therapy;Bioorganic & Medicinal Chemistry;2024-03

4. The Role of miR-29a and miR-143 on the Anti-apoptotic MCL-1/cIAP-2 Genes Expression in EGFR Mutated Non-small Cell Lung Carcinoma Patients;Biochemical Genetics;2024-02-20

5. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma;Respiratory Research;2024-01-25